Payment overview · 2025
General Payments
$107.82
1 reported records · 1 companies
Healthcare provider profile · identity verified
Ziad Alkhoury, MD
Allopathic & Osteopathic Physicians|Internal Medicine · ROCHESTER, NY · NPI 1073554796
Verified facts
What the public records show
CMS Open Payments records show Ziad Alkhoury, MD received $107.82 in general payments during 2025 across 1 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $107.82 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $107.82 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $107.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 817 | 99 |
| Levothyroxine Sodium | Levothyroxine Sodium | 602 | 60 |
| Pantoprazole Sodium | Pantoprazole Sodium | 541 | 62 |
| Gabapentin | Gabapentin | 419 | 55 |
| Sertraline Hcl | Sertraline Hcl | 408 | 37 |
| Metoprolol Succinate | Metoprolol Succinate | 373 | 37 |
| Amlodipine Besylate | Amlodipine Besylate | 334 | 50 |
| Torsemide | Torsemide | 287 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 262 | 40 |
| Metformin Hcl | Metformin Hcl | 231 | 25 |
| Lisinopril | Lisinopril | 230 | 29 |
| Eliquis | Apixaban | 229 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 222 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 213 | 26 |
| Mirtazapine | Mirtazapine | 198 | 26 |
| Trazodone Hcl | Trazodone Hcl | 181 | 28 |
| Levetiracetam | Levetiracetam | 176 | 13 |
| Baclofen | Baclofen | 166 | 12 |
| Xarelto | Rivaroxaban | 162 | 16 |
| Furosemide | Furosemide | 144 | 24 |
| Metoprolol Tartrate | Metoprolol Tartrate | 135 | 21 |
| Carvedilol | Carvedilol | 133 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 127 | 13 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 125 | 14 |
| Spironolactone | Spironolactone | 123 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 122 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 118 | 12 |
| Olanzapine | Olanzapine | 110 | 12 |
| Divalproex Sodium | Divalproex Sodium | 108 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 106 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 102 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 100 | 15 |
| Finasteride | Finasteride | 96 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 93 | suppressed |
| Simvastatin | Simvastatin | 88 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 87 | 11 |
| Losartan Potassium | Losartan Potassium | 87 | 13 |
| Aripiprazole | Aripiprazole | 85 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 81 | 14 |
| Allopurinol | Allopurinol | 76 | suppressed |
| Securesafe Pen Needle | Pen Needle, Diabetic, Safety | 76 | 18 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 75 | 16 |
| Labetalol Hcl | Labetalol Hcl | 74 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 74 | suppressed |
| Ezetimibe | Ezetimibe | 66 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 65 | 12 |
| Buspirone Hcl | Buspirone Hcl | 63 | suppressed |
| Entresto | Sacubitril/Valsartan | 62 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 61 | suppressed |
| Glimepiride | Glimepiride | 59 | suppressed |
| Glipizide | Glipizide | 58 | suppressed |
| Januvia | Sitagliptin Phosphate | 58 | suppressed |
| Famotidine | Famotidine | 56 | 14 |
| Farxiga | Dapagliflozin Propanediol | 55 | suppressed |
| Jardiance | Empagliflozin | 55 | suppressed |
| Prednisone | Prednisone | 54 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 51 | suppressed |
| Entacapone | Entacapone | 51 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 50 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 50 | suppressed |
| Cephalexin | Cephalexin | 49 | 14 |
| Venlafaxine Hcl | Venlafaxine Hcl | 49 | suppressed |
| Meloxicam | Meloxicam | 48 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 47 | suppressed |
| Omeprazole | Omeprazole | 47 | 12 |
| Bupropion Xl | Bupropion Hcl | 46 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 46 | suppressed |
| Trulicity | Dulaglutide | 46 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 45 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 44 | suppressed |
| Potassium Chloride | Potassium Chloride | 43 | suppressed |
| Glipizide Er | Glipizide | 41 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 40 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 39 | suppressed |
| Risperidone | Risperidone | 39 | suppressed |
| Digoxin | Digoxin | 38 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 36 | suppressed |
| Methotrexate | Methotrexate Sodium | 36 | suppressed |
| Myrbetriq | Mirabegron | 36 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 36 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 36 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 35 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 35 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 34 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 34 | suppressed |
| Novolog Flexpen | Insulin Aspart | 33 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 33 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 32 | suppressed |
| Memantine Hcl | Memantine Hcl | 32 | suppressed |
| Latanoprost | Latanoprost | 30 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 30 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 28 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 27 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 27 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 27 | suppressed |
| Folic Acid | Folic Acid | 26 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 24 | suppressed |
| Bumetanide | Bumetanide | 23 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | suppressed |
| Mesalamine | Mesalamine | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 23 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 23 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 22 | suppressed |
| Haloperidol | Haloperidol | 22 | suppressed |
| Methimazole | Methimazole | 22 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Ibuprofen | Ibuprofen | 21 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 20 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 20 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 20 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 20 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 19 | suppressed |
| Hydroxyurea | Hydroxyurea | 19 | suppressed |
| Lorazepam | Lorazepam | 19 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Ramipril | Ramipril | 19 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 18 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 18 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 18 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 18 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 16 | suppressed |
| Zonisamide | Zonisamide | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Nitroglycerin | Nitroglycerin | 15 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 15 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 14 | suppressed |
| Atenolol | Atenolol | 14 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 14 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 14 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Drizalma Sprinkle | Duloxetine Hcl | 13 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 13 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 12 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Nystop | Nystatin | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Cholestyramine Light | Cholestyramine | 11 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Multaq | Dronedarone Hcl | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $107.82 · 1 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error